Veoneer Inc (VNE)

Common Stock

36.95  +0.07 (+0.19%)

After market: 36.96 +0.01 (+0.03%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to VNE. VNE was compared to 43 industry peers in the Automobile Components industry. Both the profitability and financial health of VNE have multiple concerns. VNE is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

VNE had negative earnings in the past year.
In the past 5 years VNE always reported negative net income.
VNE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -22%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -20.46%
PM (TTM) -23.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

VNE has more shares outstanding than it did 1 year ago.
The debt/assets ratio for VNE has been reduced compared to a year ago.

2.2 Solvency

VNE has an Altman-Z score of 2.01. This is not the best score and indicates that VNE is in the grey zone with still only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.27 indicates that VNE is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 2.01
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.67 indicates that VNE should not have too much problems paying its short term obligations.
VNE has a Quick Ratio of 1.33. This is a normal value and indicates that VNE is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.33

More info and screens

4

3. Growth

3.1 Past

VNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.05%, which is quite impressive.
VNE shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.77%.
VNE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.67% yearly.
EPS 1Y (TTM)20.05%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q6.1%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y-9.4%
Revenue growth 5Y-5.67%
Revenue growth Q2Q-1.32%

3.2 Future

Based on estimates for the next years, VNE will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.01% on average per year.
The Revenue is expected to grow by 18.15% on average over the next years. This is quite good.
EPS Next Y45.31%
EPS Next 2Y32.27%
EPS Next 3Y27.67%
EPS Next 5Y15.01%
Revenue Next Year26.64%
Revenue Next 2Y22.93%
Revenue Next 3Y19.71%
Revenue Next 5Y18.15%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

VNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -17.53

4.3 Compensation for Growth

A more expensive valuation may be justified as VNE's earnings are expected to grow with 27.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.27%
EPS Next 3Y27.67%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VNE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Veoneer Inc

NYSE:VNE (3/31/2022, 7:04:26 PM)

After market: 36.96 +0.01 (+0.03%)

36.95

+0.07 (+0.19%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.14B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -20.46%
PM (TTM) -23.23%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.67
Quick Ratio 1.33
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)20.05%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y45.31%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)20.77%
Revenue growth 3Y-9.4%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y